Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Shrinkage of the cerebellum (cerebellar atrophy), Dysarthria, Gait ataxia, and Limb ataxia and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 3 | Dysarthria, Gait ataxia, Limb ataxia |
FAT2 encodes FAT atypical cadherin 2 (4,349 aa). Involved in the regulation of cell migration. May be involved in mediating the organization of the parallel fibers of granule cells during cerebellar development Highest expression in Brain Cerebellum (223.9 TPM) and Brain Cerebellar Hemisphere (179.8 TPM).
Spinocerebellar ataxia 45 is associated with mutations in the FAT2 gene on chromosome 5.
FAT2 is classified as a druggable target with score 0.0.
Genetic testing for FAT2 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for spinocerebellar ataxia 45 has been reported in the published literature.
Phenotype severity distribution: 5 always present features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for spinocerebellar ataxia 45.
51 publications have been identified in PubMed for spinocerebellar ataxia 45. Research spans Basic Science / Preclinical (31%), Case Report / Case Series (16%), and Epidemiology / Natural History (16%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 16 | 31% |
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 3:06 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
1 |
Shrinkage of the cerebellum (cerebellar atrophy) |
Arms and legs | 1 | Limb ataxia |
Eyes | 1 | Downbeat nystagmus |
8 |
16% |
Disease patterns and progression | 8 | 16% |
Testing and diagnosis research | 7 | 14% |
Research summaries | 6 | 12% |
Clinical study results | 5 | 10% |
Other research | 1 | 2% |
Vinciguerra M (2026). [PMID: 41771847](https://pubmed.ncbi.nlm.nih.gov/41771847/). *Cell Death Dis*. [Basic Science / Preclinical]
Zheng M (2026). [PMID: 41963867](https://pubmed.ncbi.nlm.nih.gov/41963867/). *BMC Neurol*. [Epidemiology / Natural History]
Veenhuis SJG (2026). [PMID: 41844009](https://pubmed.ncbi.nlm.nih.gov/41844009/). *Eur J Paediatr Neurol*. [Diagnostic / Biomarker]
Tran M (2026). [PMID: 41787540](https://pubmed.ncbi.nlm.nih.gov/41787540/). *Trials*. [Epidemiology / Natural History]
Matlawska M (2026). [PMID: 42096001](https://pubmed.ncbi.nlm.nih.gov/42096001/). *Cerebellum*. [Basic Science / Preclinical]
Loureiro JR (2026). [PMID: 41871099](https://pubmed.ncbi.nlm.nih.gov/41871099/). *Cell Rep*. [Basic Science / Preclinical]
Banez-Coronel M (2026). [PMID: 41422503](https://pubmed.ncbi.nlm.nih.gov/41422503/). *Cell Rep*. [Basic Science / Preclinical]
Melzer I (2026). [PMID: 42115447](https://pubmed.ncbi.nlm.nih.gov/42115447/). *Cerebellum*. [Review / Meta-Analysis]
Cui ML (2026). [PMID: 41138689](https://pubmed.ncbi.nlm.nih.gov/41138689/). *Gait Posture*. [Diagnostic / Biomarker]
Petit E (2025). [PMID: 40834346](https://pubmed.ncbi.nlm.nih.gov/40834346/). *Neurology*. [Epidemiology / Natural History]